Launch of 2020 media kit, an introduction, and a special offer from @AuManufacturing

@AuManufacturing news is pleased to announce the launch of our 2020 media kit – the first major revision to our offering to advertisers since our launch in November, 2018. The kit features prices for website and newsletter advertising, introduces the new Technology section of our website, and launches our second weekly newsletter. The new features…

Noxopharm investigates Covid-19 treatment

Drug developer Noxopharm is following up on indications that an experimental anti-cancer drug may be effective against the Covid-19 coronavirus. Melbourne’s Hudson Institute of Medical Research has identified anti-inflammatory properties of the experimental drug idronoxil, the active ingredient in the company’s anti-cancer drug candidate Veyonda. Pre-clinical models indicate the drug has the ability to treat…

The reinvention of Australian Industry Content and its ramifications

Australian Manufacturing Forum viewpoint by Mike Kalms Without anything really changing, Australian Industry Content Policy (AICP) is now unalterably different. There have been relatively cosmetic changes to how AICP is described, at what thresholds it applies, and how it might be measured, but none of these constitute wholesale change or any sort of ‘policy re-write’.…